对前列腺癌放射性药物治疗的审查

Sean R Miller1, Yuni Dewaraja2, Steven P Rowe3

  • 1Department of Radiation Oncology, University of Michigan, Ann Arbor, MI; Department of Radiology, Division of Nuclear Medicine, University of Michigan, Ann Arbor, MI.

Urologic oncology
|February 19, 2026
PubMed
概括

放射性药物治疗 (RPT) 为前列腺癌治疗提供了突破性进展. 两种FDA批准的药物,-223 (223Ra) 和-177 PSMA-617 (177Lu-PSMA-617),通过直接向癌细胞的辐射来提高生存率.